⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18195192 | 0.78 | ALDH1A1 (0.35) | — | |
| SCHEMBL16865693 | 0.73 | MEN1 (0.33) | — | |
| SCHEMBL13545949 | 0.66 | — | — | |
| SCHEMBL14514785 | 0.63 | — | — | |
| SCHEMBL5539788 | 0.62 | — | — | |
| SCHEMBL14257976 | 0.61 | — | — | |
| SCHEMBL22155240 | 0.60 | — | — | |
| SCHEMBL761380 | 0.60 | — | — | |
| SCHEMBL24568398 | 0.59 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL8325175 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4198034-A1 | BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Tuojie Biotech (Shanghai) Co., Ltd. (CN) | 2023-06-21 | — | — | EP | disclosed |
| US-20230159477-A1 | PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS | GEISTLICH PHARMA AG (CH) | 2023-05-25 | — | — | US | disclosed |
| US-20230159477-A1 | PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS | GEISTLICH PHARMA AG (CH) | 2023-05-25 | — | — | US | disclosed |
| EP-4011871-A2 | PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS | Geistlich Pharma AG (CH) | 2022-06-15 | — | — | EP | disclosed |
| US-20210163432-A1 | PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS | GEISTLICH PHARMA AG (CH) | 2021-06-03 | — | — | US | disclosed |
| US-10968190-B2 | Processes for preparing oxathiazin-like compounds | GEISTLICH PHARMA AG (CH) | 2021-04-06 | — | — | US | disclosed |
| US-10392355-B2 | Processes for preparing oxathiazin-like compounds | GEISTLICH PHARMA AG (CH) | 2019-08-27 | — | — | US | disclosed |
| US-9844555-B2 | Oxathiazine derivatives as antibacterial and anticancer agents | GEISTLICH PHARMA AG (CH) | 2017-12-19 | — | — | US | disclosed |
| US-9844555-B2 | Oxathiazine derivatives as antibacterial and anticancer agents | GEISTLICH PHARMA AG (CH) | 2017-12-19 | — | — | US | disclosed |
| WO-2017158570-A1 | METHOD OF TREATING TRIPLE NEGATIVE BREAST CANCER | GEISTLICH PHARMA AG (CH) | 2017-09-21 | — | — | WO | disclosed |
| US-20170196876-A1 | OXATHIAZINE DERIVATIVES AS ANTIBACTERIAL AND ANTICANCER AGENTS | GEISTLICH PHARMA AG (CH) | 2017-07-13 | — | — | US | disclosed |
| US-9624187-B2 | Oxathiazine derivatives as antibacterial and anticancer agents | GEISTLICH PHARMA AG (CH) | 2017-04-18 | — | — | US | disclosed |
| US-9624187-B2 | Oxathiazine derivatives as antibacterial and anticancer agents | GEISTLICH PHARMA AG (CH) | 2017-04-18 | — | — | US | disclosed |
| WO-2016098054-A1 | PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS | GEISTLICH PHARMA AG (CH) | 2016-06-23 | — | — | WO | disclosed |
| US-20160159759-A1 | OXATHIAZINE DERIVATIVES AS ANTIBACTERIAL AND ANTICANCER AGENTS | GEISTLICH PHARMA AG (CH) | 2016-06-09 | — | — | US | disclosed |
| US-20160159759-A1 | OXATHIAZINE DERIVATIVES AS ANTIBACTERIAL AND ANTICANCER AGENTS | GEISTLICH PHARMA AG (CH) | 2016-06-09 | — | — | US | disclosed |
| US-9241943-B2 | Oxathiazine derivatives as antibacterial and anticancer agents | GEISTLICH PHARMA AG (CH) | 2016-01-26 | — | — | US | disclosed |
| US-9241943-B2 | Oxathiazine derivatives as antibacterial and anticancer agents | GEISTLICH PHARMA AG (CH) | 2016-01-26 | — | — | US | disclosed |
| US-20150182534-A1 | OXATHIAZINE DERIVATIVES AS ANTIBACTERIAL AND ANTICANCER AGENTS | GEISTLICH PHARMA AG (CH) | 2015-07-02 | — | — | US | disclosed |
| US-20150182534-A1 | OXATHIAZINE DERIVATIVES AS ANTIBACTERIAL AND ANTICANCER AGENTS | GEISTLICH PHARMA AG (CH) | 2015-07-02 | — | — | US | disclosed |